No Pain, No Gain - The Agency for Health Care Policy & Research\u27s Attempt to Change Inefficient Health Care Practice of Witholding Medication from Patients in Pain by Crowley, Patricia C.
Journal of Contemporary Health Law & Policy (1985-2015) 
Volume 10 Issue 1 Article 26 
1994 
No Pain, No Gain - The Agency for Health Care Policy & Research's 
Attempt to Change Inefficient Health Care Practice of Witholding 
Medication from Patients in Pain 
Patricia C. Crowley 
Follow this and additional works at: https://scholarship.law.edu/jchlp 
Recommended Citation 
Patricia C. Crowley, No Pain, No Gain - The Agency for Health Care Policy & Research's Attempt to Change 
Inefficient Health Care Practice of Witholding Medication from Patients in Pain , 10 J. Contemp. Health L. 
& Pol'y 383 (1994). 
Available at: https://scholarship.law.edu/jchlp/vol10/iss1/26 
This Comment is brought to you for free and open access by CUA Law Scholarship Repository. It has been 
accepted for inclusion in Journal of Contemporary Health Law & Policy (1985-2015) by an authorized editor of CUA 
Law Scholarship Repository. For more information, please contact edinger@law.edu. 
NO PAIN, NO GAIN? THE AGENCY FOR
HEALTH CARE POLICY & RESEARCH'S
ATTEMPT TO CHANGE INEFFICIENT HEALTH
CARE PRACTICE OF WITHHOLDING
MEDICATION FROM PATIENTS IN PAIN
Pain is perfect misery, the worst [o]f evils.1
It is unthinkable that patients suffer needlessly when we have
the medical know-how to prevent more than half the cases of
unrelieved pain.
2
The health care industry's current standard of care concerning acute
pain is to treat the pain retroactively as needed, rather than with prevent-
ative measures. 3 This practice has its foundation in two long-standing
myths of western culture. The first myth is that enduring pain develops
character, making one a better, stronger, and more moral person.4 The
second myth is that patients will become addicted to drugs administered
for pain relief.5 These two social mores help form the basis of the medi-
1. Steven Findlay, Taking Control of Your Pain, U.S. NEws & WORLD REP., June 15,
1992, at 67, 67 (quoting John Milton, Paradise Lost).
2. UCSF School of Nursing Faculty Member Helps Draft New Guideline on Pain,
Bus. WIRE, Mar. 5, 1992, available in LEXIS, Nexis Library, Health Care File [hereinafter
New Guideline on Pain] (quoting Health and Human Services Secretary Louis W. Sullivan,
M.D.).
3. See Findlay, supra note 1, at 67 ("In ordering painkillers as needed most doctors
have simply followed the dictates of convention.").
4. Id.; see also Cynthia Starr, The Politics of Pain: A New Attitude Toward Treatment,
136 DRUG Topics, Sept. 21, 1992, at 60, 62 (declaring false the statement that pain is neces-
sary and builds character); Pain and the Doctors, WASH. POST, Mar. 14, 1992, at A22 ("Sto-
icism is out the window.").
5. See Post-Op Patients To Get More Pain Relief (National Public Radio broadcast,
Mar. 6, 1992), at 1 available in LEXIS, Nexis Library, NPR File [hereinafter NPR Broad-
cast]. "[T]here is an inherent fear among physicians of making addicts out of patients and,
as a consequence, patients are frequently underdosed." Id. (quoting oncologist Robert
Segal). This fear is codified in the Controlled Substances Act's five categories for hazard-
ous drugs that pose varying restrictions on access to drugs depending on their "potential
for abuse." 21 U.S.C. § 812(b)(2) (1988). However, a drug's classification becomes contro-
versial when supporters argue that the medicinal value of a drug outweighs the policy
problems surrounding the drug. See Alliance for Cannabis Therapeutics v. D.E.A., No. 92-
1168, No. 92-1179, 1994 U.S. App. LEXIS 2684, at *1 (D.C. Cir. Feb. 18, 1994) (rejecting an
attempt to reschedule marijuana from Schedule I to Schedule II of the C.S.A. in order to
permit physicians to prescribe it for therapeutic purposes).
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cal community's view that pain is an unavoidable and tolerable aspect of
surgery, illness, injury, and dying.6
In 1992, the United States Public Health Service's Agency for Health
Care Policy and Research (AHCPR) released clinical practice guidelines
concerning assessment and treatment of specific kinds of acute pain in
different types of patients.7 The plan "affirms that everybody ... is enti-
tled to adequate pain relief."' Announced on March 5, 1992, the guide-
lines mark the first time the United States government has published
clinical advisory standards.9 The significance of the guidelines lies in
their use as a procedural tool for the government, their recognition of
patient autonomy, and their emphasis on the governmental interest in
cost-effective health care."0 The guidelines are an outgrowth of the ex-
pansion of the hospice philosophy, the Patient Self-Determination Act of
1990," and the role of physicians as gatekeepers. 12 These three develop-
ments brought the themes of adequate pain relief, patient self autonomy,
and efficient resource allocation to the forefront of health care policy
issues.'
3
Proponents of the hospice philosophy, legislators, and bioethicists rec-
6. See Findlay, supra note 1, at 67. "Most doctors learn to give pain drugs only as
needed, even though research has shown that people do not become addicted to morphine
when it is given for a short period .... NPR Broadcast, supra note 5, at 1. Patients need
to know that "pain is not a normal part of recovery." Id.
7. Health Care, HHS Agency's First Medical Practice Guide Urges Aggressive Pain
Management, [Jan.-June] DAILY REP. FOR ExEcuTIvEs: REG., ECON. & L. (BNA) No. 45,
at A-16 (Mar. 6, 1992) [hereinafter Aggressive Pain Management].
8. Starr, supra note 4, at 60.
9. Id. (quoting Arthur Lipman, professor of clinical pharmacy and member of the
AHCPR's Acute Pain Management Guideline panel). "Nobody tells people how to prac-
tice medicine in this country." Id.
10. See id. at 60 (describing the "brand new era" for health care concerning govern-
ment sponsored advice and government's "major financial stake in cost-effective health
care"); see also Agency For Health Care Policy and Research, U.S. Dept. of Health &
Human Services, PUB. No. 92-0032, CLINICAL PRACTICE GUIDELINE, ACUTE PAIN MAN-
AGEMENT: OPERATIVE OR MEDICAL PROCEDURES AND TRAUMA 2 (1992) [hereinafter
CLINICAL PRACTICE GUIDELINE] ("[tihe importance of effective pain management in-
creases beyond patient satisfaction when additional benefits for the patient are realized,
e.g., earlier mobilization, shortened hospital stay, and reduced costs").
11. Patient Self-Determination Act of 1990, Pub. L. No. 101-508, 104 Stat. 115, 205
(codified as amended in scattered paragraphs of 42 U.S.C. § 1395).
12. For a thoughtful discussion on the concept of medical gatekeeping, see Edmund D.
Pellegrino, M.D., Rationing Health Care: The Ethics of Medical Gatekeeping, 2 J. CON-
TEMP. HEALTH L. & POL'Y 23 (1986). Dr. Pellegrino defines a gatekeeper as "the desig-
nated guardian of society's resources." Id.
13. See infra notes 80-117 and accompanying text (discussing each of the three devel-
opments in health care and their important themes echoed by AHCPR's guidelines).
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ognize the need to balance the cost-effective treatment of pain with pa-
tient autonomy.' 4 AHCPR is "charged with improving the quality,
appropriateness, and effectiveness of healthcare services."' 5 This Com-
ment considers whether AHCPR's practice guidelines on pain will bring
about such change and strike the crucial balance between effectiveness
and efficiency in pain treatment. This Comment discusses AHCPR's his-
torical development, goals, and procedures, and summarizes the agency's
eight clinical recommendations for pain management. This Comment ex-
amines the philosophical developments in hospice care, patient advance
directives, and medical gatekeeping that form the backdrop for
AHCPR's recommendations for pain maintenance. Arguments support-
ing and criticizing the practice guidelines on pain are then addressed.
This Comment concludes that AHCPR is positioned to serve as an effec-
tive catalyst for health care change because the agency strikes the crucial
balances between patient and medical provider, and between cost and
quality.
I. HISTORY AND GOALS OF THE AHCPR
On December 19, 1989, Congress passed the Omnibus Budget Recon-
ciliation Act of 1989, which established the Agency for Health Care Pol-
14. See, e.g., NPR Broadcast, supra note 5, at 1. Anesthesiologist Daniel Carr asserts
that contemporary treatment results in unnecessary pain because health care providers
only prescribe painkillers when patients request them:
By the time the patient ... pushes the nurse call button, they're already in pain.
The nurse either has to go to the patient's room or ask over the intercom what the
problem is, come in, assess it, then go look at the medication book and see what
are her options for responding to that need. Then she has to find the key to the
controlled substances closet, if the medicine is, let's say, eight milligrams of mor-
phine. Morphine comes in 10-milligram tubes. [He or sihe has to find another
nurse to witness ... discarding two milligrams, then they both have to sign on a
document that this was done. Then she goes back to the patient, gives a shot into
the patient's muscle and, after a number of minutes, let's say 15 or 20 minutes,
that's absorbed into the patient's blood.
Id.
15. Starr, supra note 4, at 60; see Warren E. Leary, More Advice for Doctors: U.S.
Guides on Treatments, N.Y. TIMES, Apr. 15, 1992, at C14. Dr. J. Jarrett Clinton, director of
AHCPR, states: "We serve as a catalyst .... We have gotten groups that normally don't
talk to each other to join around our table and determine what is best for patient care." Id.
Furthermore, the guidelines are supposed to "lay out options for care rather than picking
certain practices as standards from which health workers should not deviate." Id.; see also
Clark W. Bell, Embrace Practice Guidelines, MODERN HEALTHCARE, Apr. 13, 1992, at 44
("It's time to get serious about assessing the value of practice guidelines as a method of
containing costs and improving quality of hospital care.").
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icy and Research.16 AHCPR replaced the National Center for Health
Services Research and Health Care Technology Assessment, a subsidiary
of the United States Public Health Service (PHS).' 7 The enabling statute
directs AHCPR to-lead research projects in two distinct areas.18 First, to
achieve the goal of improving "the quality, appropriateness, and effec-
tiveness of health care services,"19 AHCPR is authorized to continue
traditional research focusing on "health care services and procedures."2"
Second, Congress authorized AHCPR to carry out new research to evalu-
ate different treatments to determine which are most effective, and to
publish the results as clinical practice guidelines.2 This new area of re-
search balances the effectiveness of a health care service against the cost
16. Omnibus Budget Reconciliation Act of 1989, Pub. L. No. 101-239, 103 Stat. 2106,
2189 (1989) (codified at 42 U.S.C. § 299 (Supp. III 1991)).
17. Ira E. Raskin & Claire W. Maklan, Medical Treatment Effectiveness Research: A
View From Inside the Agency for Health Care Policy and Research, 14 EVALUATION & THE
HEALTH PROF. 161, 162 (1991). The National Center for Health Services Research and
Health Care Technology Assessment (NCHSR) conducted research on the outcomes of
medical care. However, in 1989 the Committee on Energy & Commerce found that "car-
rying out these broad mandates requires a far greater federal effort than has been con-
ducted to date by NCHSR." H.R. REP. No. 247, 101st Cong., 1st Sess. 376 (1989),
reprinted in 1989 U.S.C.C.A.N. 1906, 2102 [hereinafter H.R. REP. No. 247].
18. Raskin & Maklan, supra note 17, at 162.
19. 42 U.S.C. § 299(b) (Supp. III 1991).
The purpose of the Agency is to enhance the quality, appropriateness, and effec-
tiveness of health care services, and access to such services, through the establish-
ment of a broad base of scientific research and through the promotion of
improvements in clinical practice and in the organization, financing, and delivery
of health care services.
Id.; see also Agency for Health Care Policy and Research, Fact Sheet, AHCPR-Commis-
sioned Clinical Practice Guidelines, Jan. 1992, at 1 (emphasizing that improving effective-
ness is the primary responsibility of the agency) [hereinafter Fact Sheet].
20. 42 U.S.C. § 299a(a)(2) (Supp. III 1991); see also Raskin & Maklan, supra note 17,
at 162 (stating AHCPR will continue the work of the National Center for Health Services
Research & Health Care Technology Assessment).
21. 42 U.S.C. § 299a(a)(2) (Supp. III 1991); see Raskin & Maklan, supra note 17, at
162.
AHCPR was created because we believe that the Federal government has a re-
sponsibility to provide leadership in the conduct of health services research - re-
search that is essential to the formation of sound public health policies. Without
better information and analysis about health care quality, access, costs, and out-
comes, we cannot expect to manage our health care system effectively.
Re-Authorization of the Agency for Health Care Policy and Research, 1992: Hearings on
H.R. 5673 Before the Subcomm. on Health and the Environment of the House Comm. on
Energy and Commerce, 102d Cong., 2d Sess. (1992) (statement of Rep. Henry Waxman).
The medical community had long rejected establishing practice guidelines because they
viewed them as outside intervention and "cookbook medicine." Id.
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to society in terms of efficiency. 22
TWo conceptual premises underlie Congress' determination that clinical
practice guidelines are necessary and effective to bring about needed
change in the health care system.23 First, there is a correlation between
variations in health care practices and differences in patient outcomes.24
Second, health care practices will change if scientific evidence showing
their inappropriateness is provided to patients and care providers.2 The
syllogism is simple: studying inconsistent treatments will provide scien-
tific proof that certain practices are inappropriate. Dissemination of the
studies' results in the form of practice guidelines serves as a catalyst to
needed change.
The practice guidelines are developed and overseen by AHCPR's Of-
fice of the Forum for Quality and Effectiveness in Health Care (Fo-
rum). 26 First, the Forum selects guideline topics. A number of factors are
weighed to determine which health conditions to research. Once a
topic is selected, the Forum convenes a panel of experts representing a
wide variety of health care providers
28 and consumer representatives.
29
After the AHCPR administrator selects the chair(s) and appoints the
nominees, the panel organizes a methodology for developing the guide-
22. Raskin & Maklan, supra note 17, at 185 n.2 (the agency's publication advocates
evaluating whether the health benefit exceeds the risk or negative consequences by a
healthy margin); see 42 U.S.C. § 299a(a)(5) (Supp. III 1991) (stating that guidelines should
be developed with respect to "health care costs, productivity, and market forces"); see also
42 U.S.C. § 299(b) (Supp. III 1991) (using the term "appropriateness" to prescribe a bal-
ancing test).
23. H.R. REP. No. 247, supra note 17, at 2102. "Research on primary care, particu-
larly research based in clinical practice, is another area of health care that has not received
adequate attention." Id.
24. Raskin & Maklan, supra note 17, at 164.
25. Id.; see 42 U.S.C. § 299a-l(a)(1) (Supp. III 1991) (asserting that prompt publica-
tion and dissemination of research results maximizes their use).
26. 42 U.S.C. § 299b (Supp. III 1991); Fact Sheet, supra note 19, at 1.
27. See 42 U.S.C. § 299a-2(b)(2) (Supp. III 1991). The Administrator must consider
"safety, efficacy, and effectiveness, and as appropriate, the cost-effectiveness, legal, social,
and ethical implications, and appropriate uses of such technologies, including consideration
of geographical factors." Id.; see also Fact Sheet, supra note 19, at 2 (commenting that these
factors include: adequacy of scientific evidence about the condition, amount of people ef-
fected by a condition, probability of being able to reduce variations in treatment associated
with it, Medicare and Medicaid need, and cost of the condition to all payers).
28. See 42 U.S.C. § 299b-2(c) (Supp. III 1991). Panelists may include physicians, spe-
cialists, nurses, or other health care experts. Fact Sheet, supra note 19, at 2. Nominations
for panelists are received after an announcement in the Federal Register. Id.
29. See 42 U.S.C. § 299b-2(b) (Supp. III 1991); Fact Sheet, supra note 19, at 2.
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lines.30 The project's scope and goals must be defined according to what
scientific evidence needs to be examined.31 Using the scope and goals as
a "road map," the panel assesses the clinical benefits and harms indicated
from the scientific evidence.32 Next, a public forum, announced in the
Federal Register, provides the opportunity for open discussions about the
health care policy issues raised by the project.33 The final guidelines are
prepared following public participation. 4 Finally, the guidelines are
widely disseminated to inform patients, physicians, and health care prov-
iders of the appropriateness of treatment options.35
The clinical practice guidelines are not intended to serve as "cookbook
medicine" mandating specific treatments and interfering with the rela-
tionship between doctor and patient.36 Instead, the guidelines are in-
tended to be a useful tool "to enhance the critical decisions of the
provider and patient in each health care encounter."37 The purpose of
the guidelines is not to force doctors to practice according to a set
formula, but to empower patients to make informed decisions about
treatment.38
II. A "NEW" APPROACH TO RELIEF FROM PAIN
One of the first practice guidelines issued by AHCPR concerned post-
operative and injury-related pain control.39 In reaching a "new"4 ap-
proach to relief from pain, an eighteen member panel co-chaired by
30. See 42 U.S.C. §§ 299b-2(a)(2)(A) & (B) (Supp. III 1991); Fact Sheet, supra note 19,
at 2.
31. Fact Sheet, supra note 19, at 2; see 42 U.S.C.A. § 299b-3(b) (Supp. III 1991).
32. Fact Sheet, supra note 19, at 2.
33. Id.
34. Id.
35. See 42 U.S.C. § 299b-3(c) (Supp. III 1991); 42 U.S.C. §§ 299a-l(a)(1)-(2) (Supp.
III 1991); Raskin & Maklan, supra note 17, at 174 (describing the process of dissemination
as strategic use of scientific methods to inform physicians, patients and health care provid-
ers about study findings).
36. Leary, supra note 15, at C14. The guidelines lay out options for care rather than
choosing certain practices as standards from which health workers should not deviate. Id.
37. Raskin & Maklan, supra note 17, at 185.
38. Barry Meier, Rx for a System in Crisis, N.Y. TIMES, Oct. 6, 1991 (Magazine), at 18
(noting that providing outcome research will "empower patients to make informed choices
about their treatment options").
39. Aggressive Pain Management, supra note 7, at A-16; see, e.g., Milt Freudenheim,
Business and Health; Combating Waste in Medical Care, N.Y. TIMES, Sept. 3, 1991, at D2
(naming the acute pain management guideline AHCPR's first).
40. The approach is not "new" to the extent that for a few decades United States
hospices advocated the preventative treatment of pain over "as needed" treatment. Starr,
supra note 4, at 61.
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Daniel B. Carr41 and Ada K. Jacox42 as well as sixteen other representa-
tives from the private sector studied the variations in clinical treatment of
pain, technical articles on pain relief, and also considered the personal
experiences of the panelists. 43 The panel determined what was the most
effective treatments and released a unique practice guideline"4 outlining
eight suggestions to improve the quality and efficiency of pain control.45
These eight recommendations attempt to strike the crucial balance be-
tween health care provider control and patient autonomy.
46
A. Summary of AHCPR's Practice Guideline for Treatment of Pain
Recognizing that "[ilt is unthinkable that patients suffer needlessly
when we have the medical know-how to prevent more than half the cases
of unrelieved pain,"'47 the Secretary of Human Health Services, Louis W.
Sullivan, issued eight recommendations for more aggressive pain control
in one of AHCPR's first clinical practice guidelines.4" First, physicians
should communicate the importance of effective pain relief to their pa-
tients and provide them with an opportunity to make informed decisions
41. Dr. Daniel B. Carr is the director of the Division of Pain Management, Depart-
ment of Anesthesia, at Massachusetts General Hospital. CLINICAL PRACrICE GUIDELINE,
supra note 10, at v.
42. Ada K. Jacox, RN, FAAN, is the Independence Foundation Chair in Health Policy
at The Johns Hopkins University School of Nursing. Id.
43. Aggressive Pain Management, supra note 7, at A-16.
44. Id. One writer describes the AHCPR guideline as unique:
While over 10,000 guidelines have been developed in the history of medical prac-
tice, AHCPR's pain management guideline is considered unique because it was
developed by an [eighteen]-member panel of pain management experts, including
a surgeon, a primary care physician, nurses, an anesthesiologist, a medical ethicist,
and a consumer/patient.
Id.
45. New Guideline on Pain, supra note 2, at 2; see infra Part II. A. and accompanying
notes (discussing the eight suggestions).
46. See supra notes 36-38 and accompanying text (describing the balancing test); see
also Wendy M. Margolis, Comment, The Doctor Knows Best? Patient Capacity for Health
Care Decision Making, 71 OR. L. REv. 909, 910-913 (1992) (describing the evolution of the
doctor-patient relationship as one from paternalism to self-determination); Clark C. Havig-
hurst, Practice Guidelines for Medical Care: The Policy Rationale, 34 ST. Louis U. L.J. 777,
801 (1990) (asserting that the expectation that consumers will be able to make choices
within the various guidelines is unrealistic).,
47. New Guideline on Pain, supra note 2, at 1 (quoting HHS secretary Louis W. Sulli-
van, M.D.).
48. Aggressive Pain Management, supra note 7, at A16; see Boyce Rensberger, 8 New
Approaches, WASH. POST, Mar. 10, 1992, at L9.
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free of the myths concerning pain.49 Second, physicians should chart a
patient's pain intensity and level of pain relief, keeping it close at hand
for reference by doctor and patient.50 Suggested methods of pain inten-
sity measurement include a descriptive words scale,5 a numeric ratings
scale,52 and a poker chip assessment method53 for use with pediatric pa-
tients.5 4 Third, hospitals should establish a threshold pain intensity level
that triggers an institutional review to determine how well the patient's
49. Clinical Practice Guideline, supra note 10, at 75. The first recommendation states
that:
[platients should be informed before surgery, verbally and in printed format, that
effective pain relief is an important part of their treatment, that talking about
unrelieved pain is essential, and that health professionals will respond quickly to
their reports of pain. It should be made clear to patients and families, however,
that the total absence of any postoperative discomfort is normally, not a realistic
or even a desirable goal.
Id.
50. Id. The second recommendation states that:
[a] simple assessment of pain intensity and pain relief should be recorded on the
bedside vital sign chart or a similar record that encourages easy, regular review by
members of the health care team and is incorporated in the patient's permanent
record. The intensity of pain should be assessed and documented at regular inter-
vals .... The degree of pain relief should be determined after each pain manage-
ment intervention ....
Id. Recognition of the importance of assessing, charting, and visually displaying (or objec-
tifying) the patient's pain is crucial, because it acknowledges the significance humans place
on the ability to quantify and measure something abstract in order to understand it and
make it real. Martin Heidegger writes: "'That is real which can be measured.' This means
that the decision about what may pass in science... for assured knowledge rests with that
measurability supplied in the objectness of nature and, in keeping with the measurability,
in the possibilities inherent in the measuring procedure." Martin Heidegger, Science and
Reflection, in THE QUESTION CONCERNING TECHNOLOGY AND OTHER ESSAYS 155, 169
(William Lovitt trans., 1977) (quoting Max Planck).
51. See CLINICAL PRACTICE GUIDELINE, supra note 10, at 116-117 (reproducing a
number of pain intensity or pain distress scales). The descriptive words scale for pain dis-
tress gives the patient choices to describe distress ranging from none to horrible and ago-
nizing. Id. at 117. Another scale offers choices for intensity of pain ranging from "no
pain" to "worst possible pain." Id. at 116.
52. The Appendix also prints a number line option to chart pain with zero equal to
"no pain" and ten as "unbearable pain." See id. at 117 (printing a number line option to
chart pain distress with zero equal to "no pain" and ten equal to "unbearable pain").
53. Id. at 121.
54. Because "[c]hildren are likely to talk less about pain than adults," the guideline
lists specific devices to assess the child's pain. Id. at 54. The poker chip technique instructs
health care providers to use four red poker chips and tell the child that "[tihese are pieces
of hurt." Id. at 121. For example, a nurse would explain to the child that one chip is "a
little bit of hurt" and all four chips are "the most hurt you could ever have." Id. Because
children often do not talk about their pain, the burden is on the health care provider to use
vigilant means of assessing the situation. Id. at 54.
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condition is being treated.5" Fourth, the agency recommends manage-
ment of pain measured by periodical sampling of clinical unit patients'
satisfaction.56 Fifth, unless contraindicated, patients should be prescribed
anti-inflammatory drugs in combination with opioid, drugs.57 "Rescue"
doses should be allowed if the first two drugs administered are ineffec-
tive.5" Sixth, patient controlled dosing of painkillers is recommended if
accompanied by special policies that limit care provider liability.5 9 Sev-
enth, alternative pain control methods6 ° should supplement drug use
rather than replace it.6 Finally, hospitals should regularly assess the effi-
55. Id. at 75. The third recommendation states that "[e]ach institution should identify
pain intensity and pain relief levels that will elicit a review of the current pain therapy,
documentation of the proposed modifications in treatment, and subsequent review of its
efficacy." Id.; see also infra notes 59, 67 (discussing a patient's significant role in this stage).
56. CLINICAL PRACTICE GUIDELINE, supra note 10, at 75-76. "At regular intervals
defined by the clinical unit and quality assurance committee, each clinical unit should as-
sess a randomly selected sample of patients who have had surgery within 72 hours." Id. at
75.
57. Id. at 76. "Unless contraindicated, every patient should receive an around-the-
clock postoperative regimen of an NSAID [nonsteroidal anti-inflammatory drug]." Anal-
gesic drug treatment should combine non-opioid "peripherally acting" analgesics on an
around-the-clock basis with opioid analgesics that are individualized to the particular pa-
tient. CLINICAL PRACTICE GUIDELINE, supra note 10, at 76. Morphine and Demerol are
two opioid drugs commonly used in the United States for acute pain relief. Id. at 17-18.
Heroin is another effective opioid for pain relief, but due to its illegal status, it is barred
from widespread use for the treatment of pain. Suzanne Marcus Stoll, Comment, Why Not
Heroin? The Controversy Surrounding the Legalization of Heroin for Therapeutic Pur-
poses, 1 J. CONTEMP. HEALTH L. & POL'Y 173, 176 (1985).
58. CLINICAL PRACTICE GUIDELINE, supra note 10, at 76.
59. Id. The AHCPR guideline states:
[sipecialized analgesic technologies, including systematic or intraspinal, continu-
ous or intermittent opioid administration or patient controlled dosing, local anes-
thetic infusion, and inhalational analgesia ... should be governed by policies and
standard procedures that define the acceptable level of patient monitoring and
appropriate roles and limits of practice for all groups of health care providers
involved. The policy should include definitions of physician and nurse accounta-
bility, physician and nurse responsibility to the patient, and the role of pharmacy.
Id. Patient controlled dosing, termed Patient Controlled Analgesia (PCA), is "a technique
that allows patients to self-administer strong agents such as meperidine and morphine."
Starr, supra note 4, at 76. PCA's often have valves that ultimately limit the amount of
anesthesia which will enter the blood stream at any given time. NPR Broadcast, supra note
5, at 1.
60. The panel acknowledged that alternative pain relief exercises provide the signifi-
cant advantage of placing the patient in an active role with respect to his or her own pain.
CLINICAL PRACTICE GUIDELINE, supra note 10, at 76.
61. Id. The guideline recognized that methods should supplement each other, not
eclipse alternate recommendations.
[Clognitive and behaviorally based interventions include a number of methods to
help patients understand more about their pain and to take into an active part in
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cacy of the first four recommendations.62
These eight recommendations are inspired by AHCPR's concern for
improving the quality, effectiveness, appropriateness, and efficiency of
health care. The AHCPR panel advocates preventative drug therapy
rather than the conventional "as needed" approach, because under the
former approach patients recover more quickly and with less expense.63
The panel notes: "physiological studiesconfirm long standing clinical im-
pressions that established pain is more difficult to suppress." 6  Health
care providers "should encourage patients to request pain medication
before the pain becomes severe and difficult to control,, 65 because pre-
ventative pain treatment results in "earlier mobilization, shortened hospi-
tal stay[s], and reduced costs."'  Patient controlled dosing67  is
recommended because patients prefer it to intermittent injections,68 and
patient satisfaction speeds recovery time.69 Finally, AHCPR squarely ad-
its assessment and control. These interventions are intended to supplement, not
replace, pharmacological interventions. Staff should give patients information
about these interventions and support patients in using them.
Id.
62. Id.
63. Id. at 5. The panel cited studies concluding that pain is enhanced without treat-
ment, and encouraging "patients to request pain medication before the pain becomes se-
vere and difficult to control." Id.
64. Id.
65. Id.
66. Id. An "as-needed" order for administering drugs may result in longer hospital
stays because of "prolonged delays while the nurse unlocks the controlled substances cabi-
net and prepares the drug for administration and until the drug takes effect." Id. at 19.
67. One patient detailed her personal experience with PCA's:
It's bad enough being sick in the hospital, confined to a bed with tubes running
out you. But then there is the pain, which often frightens and demoralizes pa-
tients, people like Sally Allman of Alexandria, Virginia ... Still, the pain has not
been nearly as bad as Sally Allman expected, thanks to a small push-button con-
trol she holds tightly in one hand. [AlIman explains] . .. [t]hat means that a
certain amount of medicine-in my case morphine-has been released into the
tube. And as long as you keep doing that at fairly frequent intervals, you really
don't feel very much pain. So this gives you a little bit more feeling of control
that you're able to help yourself.
NPR Broadcast, supra note 5, at 1.
68. CLINICAL PRACTICE GUIDELINE, supra note 10, at 21. One reason might be be-
cause patients felt a greater sense of self-determination and autonomy over their treatment
with PCA's than with intermittent injections. See, NPR Broadcast, supra note 5, at 1-2.
69. CLINICAL PRACTICE GUIDELINE, supra note 10, at 21 (describing patients who are
able to self-medicate with PCA's as having less pain and more satisfied with the pain relief
and stating that these patients tend to be discharged earlier from the hospital compared
with those given the same drug on an "as-needed" basis). One pain panel member noted:
A major advance in pain control is patient-controlled analgesia [PCA], a tech-
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dresses the addiction myth, finding that addiction to morphine or
Demerol is extremely rare when administered for less than ten days for
post-operative and injury-related pain.7° Therefore, the AHCPR calls
for a re-education of health care professionals and patients to debunk the
myths and exaggerated fears regarding opioids. 71 Although the side ef-
fects associated with opioids must be taken into account, technical com-
petence and knowledge of the drugs' benefits should reduce many of the
conflicts that clinicians face when deciding which treatment course to rec-
ommend for pain management.72
B. The Harbingers of Change
Although the AHCPR's recommendations concerning acute pain man-
agement are inconsistent with the conventional treatment of pain 73 and
contrary to cultural myths regarding pain,' 4 the AHCPR's position is not
novel. For example, a North Carolina court recently held for plaintiffs in
an action against a long term care facility that weaned a cancer patient off
nique that allows patients to self-administer strong agents such as meperidine and
morphine. Not only does PCA provide relief from pain, it also allows patients to
exercise their full dignity as people ... [Ilt's important to recognize that the pa-
tient has to be in charge of his own well-being.
Starr, supra note 4, at 72, 76 (quoting C. Richard Chapman, pain panel member).
70. Findlay, supra note 1, at 67-68 (citing scientific studies showing 1 in 3000 patients
at risk of developing addiction to drugs after treatment for ten days); see also Take Away
the Pain, HARTFORD COURANT, May 9, 1992, at D8 (finding that physicians' reluctance to
use morphine due to fear of addiction is unfounded).
71. See Starr, supra note 4, at 76.
72. CLINICAL PRACTICE GUIDELINE, supra note 10, at 4-5; but see David G. Silverman,
M.D., Letter to the Editor: Complete Pain Relief Isn't Always Possible, N.Y. TIMES, Apr. 3,
1992, at A28. It is argued that the side effects of analgesics need to be taken into account:
[a]lthough aggressive pain management may have short term and long term bene-
fits, potent analgesics such as morphine must be administered judiciously. Their
administration is often associated with nausea and vomiting; not uncommonly,
patients elect to accept some pain, rather than incur increased nausea. Further-
more, narcotics may cause dangerous respiratory depression ... [T]o avoid undue
disappointment, patients should realize that complete pain relief is not always
attainable and in addition, because of the potential side effects, does not always
mean the best therapy.
Id.
73. See CLINICAL PRACTICE GUIDELINE, Supra note 10, at 4. "Unfortunately, clinical
surveys continue to show that routine orders for intramuscular injections of opioid 'as
needed' will leave more than half of postoperative patients with unrelieved pain due to
undermedication." Id. (citations omitted).
74. See supra notes 3-6 and accompanying text (discussing the cultural myths sur-
rounding pain).
394 Journal of Contemporary Health Law and Policy [Vol. 10:383
analgesics, thereby'subjecting the individual to acute pain.75 Although
this case did not involve post-operative or trauma-causing pain, this case
illustrates changing notions regarding the use of opioid analgesics for
pain relief.76 The AHCPR panel's recommendations were also foreshad-
owed by other health law policies, including the hospice movement's em-
phasis on preventative medication,77 the idea of patient autonomy
incorporated in the Patient Self Determination Act of 1990,78 and the
bioethical concept of medical gatekeeping.79
1. Preventative Dosing and the Hospice Philosophy
The hospice movement, originally developed for terminally ill patients,
is a forerunner of the AHCPR's preemptive pain control recommenda-
tion.8 0 The hospice philosophy differs from traditional health care treat-
ment in its emphasis on the role of effective pain relief.81
[Plain relief is central to the hospice mode of care. The chronic,
intractable pain of many terminal illnesses, particularly cancer,
can leave an individual physically drained, emotionally spent
75. Daniel Q. Haney, Control of Pain Gains Priority in Cancer Treatment Centers;
Medicine: More and More Doctors are Paying Attention to Patients' Discomfort, L.A.
TIMES, Mar. 15, 1992, at A-1 (noting that the patient's family was awarded 15 million dol-
lars from the nursing home).
76. Id.. Professor Michael Heller, University of Pittsburgh School of Medicine, de-
scribes this case as the first time that not relieving someone's pain was considered a "sua-
ble offense". Id.
77. See infra notes 80-90 and accompanying text (discussing hospice's philosophy in
support of preventative medication).
78. See infra notes 91-103 and accompanying text (overview of the Patient Self Deter-
mination Act of 1990).
79. See infra notes 104-17 and accompanying text (discussing the bioethics of medical
gatekeeping).
80. Starr, supra note 4, at 61.
There has been tremendous acceptance of hospice care in the United States.
From the first American hospice in 1974, there are now approximately 1700 hos-
pices serving 200,000 patients per year. There has also been a growing interest
and understanding by the medical profession in pain and symptom control and
appropriate palliative care.
Robert J. Miller, Hospice Care as an Alternative to Euthanasia, 20 LAW, MED. & HEALTH
CARE 127, 127-28 (1992). The development of the hospice movement is beyond the scope
of this Comment. For an in-depth discussion of the topic see Margaret A. Crowley, Com-
ment, The Hospice Movement: A Renewed View of the Death Process, 4 J. CONTEMP.
HEALTH L. & POL'Y 295 (1988); Robert G. Twycross, Why Palliative Medicine?, 39 HENRY
FORD Hosp. MED. J. 77 (1991).
81. Crowley, supra note 80, at 302-03. One difference between a hospice and a hospi-
tal is the focus of care provided by the two. While hospitals focus on providing curative
care, hospices emphasize palliative care, care that tends to alleviate pain without actually
curing it, because their patients are facing impending death. Id. at 295-96.
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and thoroughly depressed. [Hospice physicians have] long ad-
vocated the vital role of pain relief in the care of the terminal
patient and [are] pioneer[s] in the use of polypharmacy as part
of the palliative care provided such patients. Providing drugs to
patients on a regular basis has proven to be successful in
preventing pain from occurring instead of relieving it once it has
occurred.8 2
Accordingly, the hospice philosophy is a harbinger for the effective
treatment of post-operative trauma pain in two important ways. First, the
hospice movement advocates the use of combined medications, for ex-
ample combining peripherally acting medications with opioid
analgesics.8 3 Second, the hospice movement recommends administering
drugs on a preemptive basis rather than an "as needed" basis.' These
two approaches to health care are echoed in the AHCPR's recommenda-
tions for post-operative pain relief.85 The AHCPR's fifth recommenda-
tion suggests combining opioids with non-opioids to maximize patient
comfort.86 Likewise, the AHCPR observes that "prevention is better
than treatment.
87
Beyond emphasizing the importance of preventative dosing for effec-
tive palliative care, the hospice movement advocates dispelling the myth
that pain is a necessary character building aspect of life.' A hospice ex-
pert writes: "[Tihe pain that too often comes with terminal illness is an
utter waste. It does not serve to warn, or to instruct. Instead, it simply
blots out ... all ability to perceive, to think sanely, or to be in any way
master of the situation."89 The AHCPR's attempt to change the out-
dated social myths regarding acute pain control mirror the hospice ap-
82. Id. at 303 (footnotes omitted). Polypharmacy is the combined use of different
drugs in one situation to maximize pain relief and alertness. Id. at 303 n.65.
83. Id. at 303.
84. Id. at 302-04; see generally Starr, supra note 4, at 61. "Interest in the treatment of
pain began to intensify during the past two decades with.., the growth of the American
hospice movement." Id.
85. See supra notes 49, 57 and accompanying text (discussing the first and fifth
recommendations).
86. CLINICAL PRACICE GUIDELINE, supra note 10, at 76.
87. Id. at 5; see also Crowley, supra note 80, at 303 (stating that preemptive dosing is
more effective than "as needed" treatment).
88. See, e.g., SANDOL STODDARD, THE HospicE MOVEMENT: A BETrER WAY OF
CARING FOR THE DYING 138-41 (rev. ed. 1992) (employing Plato's method of the Socratic
dialogue by depicting a discussion between two individuals with the supporter of palliative
care winning the debate over the critic).
89. Id. at 140.
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proach to care for the dying in this respect.9
2. Autonomy and the Patient Self-Determination Act of 1990
The Patient Self-Determination Act of 19909' (PSDA) is a federal fore-
runner to AHCPR's pain control practice guideline. 2 In the PSDA,
Congress "recognized the individual's basic right to control the course of
her own medical treatment."9 The PSDA attempts to increase public
awareness of individuals' state-law rights to play a significant role in the
decision making process.94 It also stresses the importance of advance di-
rectives and promotes their use.95 Advance directives are defined as any
"written instruction, such as a living will or durable power of attorney for
health care ... ." One purpose of advance directives is to return the
right to refuse treatment to the patient, thereby enhancing the patient's
role in the decision making process. 7 The PSDA attempts to increase
public awareness of their rights, advance directives and to promote their
use.9" Dissemination of information by federal and state governments on
advance directives is now required.99 States that fail to comply with the
mandates of the PSDA risk losing Medicare and Medicaid funding.1"
Enhancing the flow of information regarding living wills and proxies ben-
90. See Staff, supra note 4, at 61.
91. Pub. L. No. 101-508, 104 Stat. 115, 205 (codified as amended in scattered
paragraphs of 42 U.S.C. § 1395).
92. For a thorough explanation of the history behind the PSDA see Michael A.
Refolo, The Patient Self-Determination Act of 1990: Health Care's Own Miranda, 8 J. CON-
TEMP. HEALTH L. & POL'Y 455, 455-68 (1992).
93. Margolis, supra note 46, at 915.
94. Id.
95. Refolo, supra note 92, at 457. "By disseminating information about advance direc-
tives, the PSDA attempts to take the decision-making role away from the third party and
ensure that the decisions uphold the interests of the patient, the families, and the physi-
cians in each case." Id. at 469.
96. 42 U.S.C. § 1395cc(f)(3) (1988 & Supp. 11 1990). A broad definition of advance
directives includes "any statement made by an individual, while competent, of the individ-
ual's preferences for any treatment decision, or for the process of decision-making, in the
event the person loses the ability to make decisions." Id. (quoting AMERICAN BAR Ass'N,
COMM'N ON LEGAL PROBLEMS OF THE ELDERLY, PATIENT SELF-DETERMINATION ACT
STATE LAW GUIDE, 16 (1991)). This broad definition was limited by the Patient Self-De-
termination Act to only include written instructions recognized under applicable state law.
See 42 U.S.C. § 1395cc (f)(1)(A)(i) (1988 & Supp. II 1990) (for example, a living will,
proxy, or power of attorney). Informal oral instructions made by individuals to their doc-
tors are not included within the PSDA. Refolo, supra note 92, at 455 n.2.
97. Id. at 468.
98. Refolo, supra note 92, at 457.
99. Id. at 468.
100. Id. at 457. The PSDA is uniquely able "to compel states to work for increased
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efits society. "[The PSDA] benefits the people both individually and col-
lectively. In an individual capacity, it promotes a person's right to choose
to end his life; in a collective capacity, it promotes the public's rights by
decreasing wasted resources that result from unwanted and unnecessary
medical treatment."'' 1
The policy underlying the PSDA is similar to the underpinnings of the
AHCPR's pain control recommendations. 1°2 First, the AHCPR guide-
lines instruct health care providers to allow patients to voice preferences
when the health care providers are implementing a post-operative pain
plan.' 013 This instruction is similar to the PSDA's advocacy of advance
directives. Secondly, the AHCPR guidelines and the PSDA both pro-
mote change within the health care community by recognizing the impor-
tance of patient autonomy and the patient's right to make informed
decisions.
3. The Bioethical Notion of Medical Gatekeeping
The medical gatekeeper concept is also a precursor to the approach
taken in AHCPR's recommendations on pain management. Medical
gatekeeping is the role physicians perform as the guardians of society's
limited health care resources.' °4 Bioethicists disagree over what role the
physician should play in allocating health care resources.'0 The debate
awareness of their various advance directive statutes by threatening them with the loss of
medicare and medicaid funding." Id.
101. Id. at 468. Living wills are also useful when requesting treatment. Tamar Lewin,
Led By Court, Hospitals Take New Interest in Living Wills, N.Y. TIMES, July 23, 1990, at
Al, A13.
102. See supra notes 23-25 and accompanying text (discussing the syllogism).
103. See CLINICAL PRACTICE GUIDELINE, supra note 10, at 8, 11.
A member of the health care team should advise the patient that a score above
some predetermined criterion of the patient's choosing ... will result in a dose
increment or other intervention. The patient's negotiation of this criterion is par-
ticularly important if the patient fears overmedication or intends to cope psycho-
logically with the pain. Patient preferences should be supported.
Id.
104. GEORGE P. SMITH, II, BIOETHICS AND THE LAW: MEDICAL, SOCIO-LEGAL AND
PHILOSOPHICAL DIRECTIONS FOR A BRAVE NEW WORLD 31-33 (1993).
105. See generally Pellegrino, supra note 12, at 23 (articulating view that physicians
"must become the 'gatekeeper' ... of society's resources"); SMrrH, supra note 104, at 31-33
(describing the tension between paternalism and autonomy which underlies the debate
over medical malpractice); cf Linda B. Johnston, Note, Playing Doctor: Who Controls the
Practice of Medicine?. 66 ST. JOHN'S L. REV. 425, 426-27 (1992) (noting that increased
governmental intervention and "the increase in hospitals control over the selection, man-
ner and method of doctors services" has severely curtailed physician's autonomy in making
decisions).
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centers on whether rationing society's resources to reduce costs is an ethi-
cal task for the health care provider, who also has obligations to patients,
herself, and society."
Bioethicists differentiate between three roles physicians may assume as
gatekeepers: the negative gatekeeper, the positive gatekeeper, and the de
facto gatekeeper." 7 The first two roles are used to describe the negative
and positive financial incentives that effect a physician's allocation deci-
sions."°8 Gatekeeping decisions based on these coercive measures may
result in ethically unsound situations. 0 9 For example, negative medical
gatekeeping may result in a conflict of interest" 0 when a "physician is
106. See Pellegrino, supra note 12, at 23. "To what extent can, or should, the physician
serve simultaneously the needs of his patients, his own interests, and those of society?" Id.
For a discussion on the implications of rationing and the articulation of views for and
against resource allocation, see Jan Blustein & Theodore R. Marmor, Cutting Waste by
Making Rules: Promises, Pitfalls, and Realistic Prospects, 140 U. PA.L. REV. 1543, 1569
(1992)(questioning whether rule-making will cut waste in a straight forward manner be-
cause doctors are not willing to "unilaterally" stop inefficient practices); Leonard M.
Fleck, Just Health Care Rationing: A Democratic Decisionmaking Approach, 140 U. PA. L.
REV. 1597, 1634 (1992) (pointing out that health care rationing is a moral problem requir-
ing public participation in reaching a democratic consensus on the issue); Edward B.
Hirshfeld, Should Ethical and Legal Standards for Physicians Be Changed to Accommodate
New Models for Rationing Health Care?, 140 U. PA. L. REV. 1809, 1845-46 (1992) (advocat-
ing retaining the present patient-interest standard of care and questioning whether ration-
ing is necessary); David Mechanic, Professional Judgment and the Rationing of Medical
Care, 140 U. PA. L. REV. 1713, 1753-54 (1992) (asserting that "more stringent rationing of
medical care is inevitable").
107. See SMITH, supra note 104, at 31-32. Negative gatekeeping results from the pres-
sure on a doctor to restrict medical services. Id. at 32. In contrast, positive gatekeeping
occurs when a doctor is constrained to increase services for profit maximization. Id. The
third catagory of medical gatekeepers is the de facto type:
[a]s a de facto 'gatekeeper,' the unavoidable conflict the physician encounters is
over his duty to ensure that monies expended for health maintenance or restora-
tion are used in an effective and beneficial manner .... Ideally, when ethically
performed, the de facto gatekeeper's responsibilities present no real conflict with
the patient's good; for not only are economics and ethics in congruence, but also
are individual and social good as well as the doctor's and patient's interests.
Id. at 31-32.
108. See id. at 23.
109. See Pellegrino, supra note 12, at 24 (arguing "that the line of reasoning that leads
to rationing and physician gatekeeping is morally unsound and factually suspect").
110. Id. at 29.
Efforts at cost-containment are not, in themselves, immoral, and, as noted above,
are morally mandatory when in the best interests of the patient. They violate
those interests if, for whatever reason, they deny needed services or induce the
patient to demand, or the physician to provide, unneeded services. The ethical
dilemmas of gatekeeping therefore arise out of the way economic incentives and
disincentives modify the physician's freedom to act in the patient's behalf.
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placed under constraints of self-interest to restrict the use of medical
services of all kinds but particularly those that are most expensive."'
111
Similarly, in a positive gatekeeping situation, profit motive is the most
important factor between a patient and doctor, and medical ethics are
displaced by business considerations. 1 2 Nevertheless, bioethicists recog-
nize that physicians have certain unavoidable gatekeeping functions.
1 3
"The unavoidable fact is that the physician recommends what tests, treat-
ments, medications, operations, consultations, periods of hospitalization,
or nursing homes the patient needs.""14 Thus, de facto gatekeeping rec-
ognizes the doctor's role in monitoring health care expenses. 5 The
AHCPR's pain management guidelines advocate health care providers
functioning as de facto gatekeepers:
1 6
Health care is both a technical and an ethical enterprise. The
ethical obligation to manage pain and relieve the patient's suf-
fering is at the core of a health care professional's commitment.
While medical treatments often involve risks and burdens, any-
thing harmful to the patient, including post-operative pain,
should be minimized or prevented if possible. The ethical im-
portance of pain management is further increased when addi-
tional benefits for the patient are realized-earlier mobilization,
shortened hospital stay, and reduced costs. If inadequate pain
management results from a clinician's conflict between reducing
pain and avoiding potential side effects and/or legal liability,
achieving greater technical competence and knowledge of risks
and benefits can help reduce such conflicts."1
7
In effect, the guidelines and accompanying recommendations place eco-
nomics and ethics in congruence and avoid the ethical failures in both
negative and positive gatekeeping. Thus, the guidelines on pain manage-
ment strike a balance between the importance of patient autonomy and
the role physicians must play as de facto gatekeepers.
111. Id. at 27 (describing the negative gatekeeper role).
112. Id. at 32-33 (describing the positive gatekeeper role).
113. Id. at 26; cf. Margolis, supra note 46, at 919 (arguing that decision-making capacity
should serve as a gatekeeper balancing autonomy with beneficence).
114. Pellegrino, supra note 12, at 26.
115. Id. at 27 (describing this type of gatekeeping as a "legitimate" and "morally bind-
ing responsibility" of physicians).
116. See CLINICAL PRACTICE GUIDELINE, supra note 10, at 4-5.
117. Id.
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III. WILL THE AHCPR GUIDELINES BE AN EFFEcrIvE CATALYST TO
CHANGE?
AHCPR's pain guidelines are criticized for both specific weaknesses
and as a whole. First, the medical community has long been suspicious of
developing guidelines for medical care "because of fears that they could
lead to standardized 'cookbook medicine' that dictate specific treatments
and interfere with the doctor-patient relationship."1 ' Therefore, the
AHCPR guidelines are criticized by some members of the medical pro-
fession as an "unnecessary intrusion" upon health care. !"9 There are also
pragmatic questions over how the research will be used, 2° because un-
like the PSDA's threats to discontinue Medicare and Medicaid fund-
ing,"' the AHCPR has no authority to enforce the guidelines once
disseminated.' 22 In addition, opponents are specifically concerned about
the pain guidelines recommendations on the use and dangers of mor-
phine. 23 For example, benign use of morphine is criticized because of its
serious side effects, including nausea and respiratory depression.
124
Proponents of the AHCPR guidelines argue that these criticisms are
not fatal to the guidelines' potential for improving the efficiency and ef-
fectiveness of pain management. Doctor and health care provider organi-
zations support AHCPR's guidelines as an encouraging "effort to reduce
wasteful defensive medicine and better use health resources.' 125 Sup-
porters also note that the guidelines are a means to make patients equal
partners in the decision-making process. 26 In response to the "cookbook
medicine" criticism, proponents emphasize that individual patients and
health care providers are not forced to follow a prescribed treatment, but
instead are empowered with information to make well reasoned deci-
118. Leary, supra note 15, at C14.
119. Bell, supra note 15, at 44.
120. Terese Hudson, Clinical Quality Initiatives: The Search for Meaningful-and Accu-
rate- Measures: Government Programs Garner Interest and Questions, Hosps., J.A.H.A.,
Mar. 5, 1992, at 26, 38.
121. Refolo, supra note 92, at 457.
122. See Controlling Unnecessary Pain After Surgery (National Public Radio broadcast,
Mar. 29, 1992), at 1 available in LEXIS, Nexis Library, NPR File.
123. See Silverman, supra note 72, at A28 (illustrating the concerns regarding opioid
side effects).
124. Id.
125. See Leary, supra note 15, at C14 (quoting Dr. James S. Todd, executive vice presi-
dent of the American Medical Association).
126. See Findlay, supra note 1, at 68.
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sions: 127 "[M]ost doctors prefer patients who are informed .... A guide-
line can help patients see what the choices are and work with their doctor
to make a decision."'
128
In response to pragmatic questions of how the guidelines should be
implemented, proponents look to hospitals to "test and use" AHCPR's
recommendations. 129 Hospitals are the best place for the implementation
of changes in pain management.130 Each hospital is in the best position
to implement the AHCPR's practice guidelines by organizing teams of
surgeons, nurses, pharmacists, and anesthesiologists to consult daily with
patients on treatment options.13 ' The American Medical Association is
also releasing a guide to help hospitals implement AHCPR's guide-
lines.'3 2 Once hospitals begin to implement the changes in pain manage-
ment, state and federal governments, and private payers 33 can monitor
the results to determine if the AHCPR's guidelines are an effective and
efficient catalyst to change. 34
The guidelines also could play a significant role within President Clin-
ton's proposed Health Security Act.' 35 The Health Security Act would
establish the National Health Board (NHB), an agency charged with es-
127. See Meier, supra note 38, at 18; see also Findlay, supra note 1, at 68 (asserting that
patients should have a say in the doctor's decision regarding pain relief).
128. Steven Findlay, Medicine by the Book, U.S. NEWS & WORLD REP., July 6, 1992, at
68 (quoting Dr. James S. Todd, executive vice president of the American Medical
Association).
129. Hudson, supra note 120, at 38. The AHCPR guidelines are generally supported,
but, questions remain as to how the health care providers will be able to use them. Id.
"[A]mid these implementation questions, sources at the American Hospital Association,
the American Medical Association and the Health Care Financing Administration agree
that hospitals are uniquely positioned to test and use the government-generated data." Id.
130. Bell, supra note 15, at 44; see also Havighurst, supra note 46, at 800-01 (insisting
that the AHCPR preserve pluralism by developing competing guidelines from which hos-
pitals may choose).
131. Bell, supra note 15, at 44; see supra notes 49-62 and accompanying text for a dis-
cussion of the steps a hospital should take when implementing the clinical guidelines.
132. Bell, supra note 15, at 44.
133. The effect the clinical practice guidelines will have on private malpractice actions
is beyond the scope of this Comment. For thorough discussions of the debate see Troyen
A. Brennan, Practice Guidelines and Malpractice Litigation: Collision or Cohesion?, 16 J.
HEALTH POL., POL'Y & L. 67 (1991) (asserting that practice guidelines will act as useful
evidence towards a standard of care); cf Edward B. Hirshfeld, Practice Parameters and the
Malpractice Liability of Physicians, 263 JAMA 1556 (1990) (arguing that practice guide-
lines might increase liability exposure for health care providers who do not comply with
them).
134. Bell, supra note 15, at 44.
135. 139 CONG. REC. 2571 (daily ed. Oct. 28, 1993) (statement of Rep. David E.
Bonior).
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tablishing national standards and overseeing the administration of the
health care system.'36 The NHB would function as an independent regu-
latory agency, similar to the Securities and Exchange Commission
(SEC). 37 "Under the SEC model, the [NHB] would oversee a private
marketplace to ensure that rules are obeyed and that information is avail-
able so that consumers could make informed decisions on what health
care coverage they needed and what it would cost.' 138 For example, the
NHB may require regional alliances to inform customers if insurance pol-
icies and hospitals are incorporating AHCPR clinical practice guidelines
into health care coverage.139
"This vision of how guidelines might be used opens new possibilities for
competition under conditions of informed consumer choice."' 4° In this
way, an alliances' willingness to adopt the AHCPR recommendations is a
factor individual consumers will consider when choosing between com-
peting insurers."' As one of the AHCPR's first completed clinical prac-
tice studies the guideline on acute pain management is in a prime position
to change the standard of care for pain treatment at the initial stages of
health care reform in the United States.
IV. CONCLUSION
The health care industry's current standard of care regarding acute
pain management should be changed because it is inefficient. The myths
that persist about the pain associated with operations, injuries and other
traumas result in ineffective, inappropriate and inefficient treatment. The
AHCPR's guidelines provide clinical guidance options to alleviate this
problem by incorporating the ideals of preemptive dosing, self-autonomy
and de facto gatekeeping. In so doing, the AHCPR practice guidelines
136. H.R. 3222, 103d Cong., 1st Sess., 139 CONG. REc. 2571 (daily ed. Oct. 28, 1993)
(statement of Rep. David E. Bonoir) (creating the NHB) [hereinafter H.R. 3222]; see also
Stephen Barr, Many Health Care Experts Sound Alarm Over Board: Agency Proposed by
Clinton Would Have Wide Powers, WASH. POST, Sept. 22, 1993, at A4.
137. Barr, supra note 136, at A4.
138. Id.
139. H.R. 3222, supra note 136, at 2573 (listing the duties and responsibilities of the
NHB); see generally Health Care Relief for Consumers, N.Y. TIMES, Sept. 20, 1993, at A18
(stating that under the Health Security Act people "would choose an insurance policy
among those made available by a regional purchasing cooperative").
140. Havighurst, supra note 46, at 800.
141. See Health Care Relief for Consumers, supra note 139, at A18.
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are a catalyst so that health care providers may implement necessary
change.
Patricia C. Crowley

